Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio R Cabral

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Anti-beta(2)GP-I and anti-prothrombin antibodies generated by phage displayJavier Cabiedes, Antonio R Cabral
Autoimmunity Reviews|July 2, 2005
Anti-beta 2-glycoprotein-I antibodies in scFv formatJavier Cabiedes, Antonio R Cabral
Blood|July 14, 2010
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up studyLucía Comellas-Kirkerup, Gabriela Hernández-Molina, Antonio R Cabral
Clinical and Experimental Rheumatology|January 12, 2013
The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndromeGabriela Hernández-Molina, Grissel Espericueta-Arriola, Antonio R Cabral
Autoimmunity Reviews|February 10, 2007
Autoimmune inflammation from the Th17 perspectiveJanette Furuzawa-Carballeda, María Inés Vargas-Rojas, Antonio R Cabral
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|December 1, 2005
Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodiesMartha E Viveros, Javier Cabiedes, Elba Reyes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndromeFrancisco Salcido-Ochoa, Javier Cabiedes, Donato Alarcón-Segovia, et al.
Clinical and Experimental Rheumatology|January 5, 2024
The meaning of non-criteria clinical manifestations in a real-life primary antiphospholipid syndrome cohortGabriela Hernández-Molina, Cindy Maldonado-García, Mariana Gamboa-Espíndola, et al.
The Journal of Rheumatology|February 4, 2003
Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trialJanette Furuzawa-Carballeda, Antonio R Cabral, Martín Zapata-Zuñiga, et al.
International Journal of Rheumatic Diseases|March 7, 2017
Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapyGabriela Hernández-Molina, Itzel González-Pérez, Carlos Pacheco-Molina, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Anti-beta(2)GP-I and anti-prothrombin antibodies generated by phage displayJavier Cabiedes, Antonio R Cabral
Autoimmunity Reviews|July 2, 2005
Anti-beta 2-glycoprotein-I antibodies in scFv formatJavier Cabiedes, Antonio R Cabral
Blood|July 14, 2010
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up studyLucía Comellas-Kirkerup, Gabriela Hernández-Molina, Antonio R Cabral
Clinical and Experimental Rheumatology|January 12, 2013
The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndromeGabriela Hernández-Molina, Grissel Espericueta-Arriola, Antonio R Cabral
Autoimmunity Reviews|February 10, 2007
Autoimmune inflammation from the Th17 perspectiveJanette Furuzawa-Carballeda, María Inés Vargas-Rojas, Antonio R Cabral
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|December 1, 2005
Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodiesMartha E Viveros, Javier Cabiedes, Elba Reyes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 17, 2006
Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndromeFrancisco Salcido-Ochoa, Javier Cabiedes, Donato Alarcón-Segovia, et al.
Clinical and Experimental Rheumatology|January 5, 2024
The meaning of non-criteria clinical manifestations in a real-life primary antiphospholipid syndrome cohortGabriela Hernández-Molina, Cindy Maldonado-García, Mariana Gamboa-Espíndola, et al.
The Journal of Rheumatology|February 4, 2003
Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trialJanette Furuzawa-Carballeda, Antonio R Cabral, Martín Zapata-Zuñiga, et al.
International Journal of Rheumatic Diseases|March 7, 2017
Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapyGabriela Hernández-Molina, Itzel González-Pérez, Carlos Pacheco-Molina, et al.
Pageof 3